Acutus Reports (AcQForce Flutter Study) Results of AcQBlate Force Sensing Ablation Catheter and System for Right Atrial Typical Flutter
Shots:
- The (AcQForce Flutter Study) evaluating the safety & efficacy of AcQBlate FORCE sensing ablation catheter & system in 110 patients with a right atrial typical flutter at 21 sites globally
- The trial met its 1EPs i.e., the results showed 94% acute success with no serious AEs and significantly less ablation time. Additionally, the study demonstrated comparable outcomes to historic controls with significantly shorter ablation time and lower fluid volumes & the results were presented at AF Symposium in Boston
- The AcQBlate FORCE sensing ablation catheter and system received CE Mark in 2020 & is commercially available in the EU. The system provides consistent, effective therapeutic delivery during cardiac ablation procedures
Ref: Globenewswire | Image: Acutus
Related News:- Acutus Medical's AcQMap Contact Mapping Software Receives CE Mark Approval
Click here to read the full press release
Tags
Neha is a Senior Editor at PharmaShots. She is passionate and very enthusiastic about recent updates and developments in the life sciences and pharma industry. She covers Biopharma, MedTech, and Digital health segments along with different reports at PharmaShots. She can be contacted at connect@pharmashots.com.
